Monoclonal antibodies selective for prostate cancer and diagnostic immunoassay for prostate cancer
AssigneeSloan-Kettering Institute for Cancer Research
InventorsMichel Bazinet, Richard J. Cote, Lloyd J. Old
Life of this patent
Estimating the term…
Abstract
Four monoclonal antibodies are found which selectively identify prostate cancer. These monoclonals are therefore useful in diagnosis and differential diagnosis of prostate cancer.
Claims3
A panel of monoclonal antibodies consisting essentially of the monoclonal antibody P25.48 (ATCC No. HB 9189), the monoclonal antibody P25.91 (ATCC No. HB 9120), and the monoclonal antibody P25.15 (ATCC Accession No. HB 9140) labelled with detectable markers.
A method of diagnosing prostate cancer by immunohistological staining of prostate tissues using monoclonal antibody P25.48 produced by the hybridoma cell line ATCC 9119.
A method of diagnosing prostate cancer by immunohistological staining of prostate tissues using monoclonal antibody P25.48 produced by the hybridoma cell line ATCC 9120.
Dependencies are inferred from the claim text.